Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
amlodipine + losartan
- Development stage
- Phase 1
- Lead developer
- Hanmi Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Amlodipine + losartan is a combination medication used to treat hypertension. It combines a calcium channel blocker (amlodipine) and an angiotensin II receptor antagonist (losartan). Amlodipine works by dilating blood vessels, while losartan blocks the effects of angiotensin II, a hormone that increases blood pressure. Together, they effectively lower blood pressure by relaxing and widening blood vessels.
- Brand names
- Amlokind-LLosacar-ACovamloRepace-ATozamZilos-AMNusar-AMAsomex-LT
- Other names
- amlodipine/losartan
02
Targets
AGTR1 (Angiotensin II Type-1 receptor)LTCC (Voltage-gated calcium channel (L-type))
Beyond the preview
Go deeper on amlodipine + losartan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on amlodipine + losartan.